Scientific Program
| Time | Room A [English] | Faculty |
|---|---|---|
| 08:20-08:30 | Opening and Course Introduction | Mani Vannan (USA) |
| 08:30-09:50 | New Concepts in VHD in 2026 II | Sak Lee (Korea), Mungun-Ulzii Khurelbaatar (Mongolia) |
| Lifetime Management in SHD: Integrating Risk Control and Strategic Intervention Timing | Daisuke Hachinohe (Japan) | |
| CCTA for Valve Intervention: New Standard or Selective Alternative? | Ricardo Budde (Netherlands) | |
| Aortic Valve Preservation: From Geometric Principles to Hemodynamic Performance | Joon Bum Kim (Korea) | |
| Antithrombotic Management after TAVI | Patrizio Lancellotti (Belgium) | |
| When "Moderate" Is Not Benign: Rethinking Risk in Multivalvular VHD | Sung-Ji Park (Korea) | |
| Panel Discussion | Toshiyuki Kimura (Japan), William Kok Fai Kong (Singapore), Zhe-Hao Piao (China), Joon Hwa Hong (Korea) |
|
| 09:50-10:10 | Coffee Break | |
| 10:10-11:00 | Plenary Lectures | Patrizio Lancellotti (Belgium), Yang Soo Jang (Korea) |
| TBD | Edward Chen (USA) | |
| CT at the Center of Structural Heart Intervention: From Patient Selection to Lifetime Management | Ricardo Budde (Nethaland) | |
| Discussion | ||
| 11:00-12:20 | Aortic Valve Disease: Current Strategies for Management and Unresolved Questions | Kian Keong Poh (Singapore), Jong-Seon Park (Korea) |
| Management of AR: Current Strategies and Unresolved Questions | Karlie Li-Tan Yang (Taiwan) | |
| Structural Heart Echocardiography in Complex TAVR Procedures (Low Coronary Height and AR) | Ka Ho Kevin Kam (Hong Kong) | |
| Specific Anatomical Features in Patients in Asia - Leaflet Modifications for TAV-in-SAV | Simon Lam (Hong Kong) | |
| Totally Endoscopic Aortic Valve Replacement with 3D Visualization: UMC's Experience | Hoang Dinh Nguyen (Vietnam) | |
| Imaging-Guided Decision Making in Aortic Stenosis and TAVI - What May Impact the Outcome? | Masaki Izumo (Japan) | |
| Panel Discussion | Hoai Thi Thu Nguyen (Vietnam), Xueyan Lin (China), Smonporn Boonyaratavej Songmuang (Thailand), Ana Lascu (Romania) |
|
| 12:20-13:30 | Luncheon Session (Sponsored Session)-Edwards | Young Won Yoon (Korea) |
| Aim for Exceptional: Valve Performance & Durability in Sapien 3 Ultra Resilia | Ung Kim (Korea) | |
| Why Index Valve Matters: Looking Beyond the Procedure | Jung-Hee Lee (Korea) | |
| 13:30-14:40 | HEART TEAM AT WORK, Learn from Case: Tricuspid Regurgitation | Alex Lee (Hong Kong), Joon Bum Kim (Korea) |
| Patient Presentation and Imaging Analysis | Sun-Hwa Lee (Korea) | |
| Discussion and Audience Interaction | ||
| Anatomy and Mechanisms of Tricuspid Regurgitation: Imager's Point of View | Chi Young Shim (Korea) | |
| Tricuspid Valve Repair: Surgery or Transcatheter?: Surgeon's Point of View | Hyunggon Je (Korea) | |
| When and Where Does T-TEER and TTVR Fit in and More: Interventionist's Point of View | Atsushi Sugiura (Japan) | |
| Heart Team Discussion and Audience Interaction | ||
| How Did Our Case End | Sun-Hwa Lee (Korea) | |
| Heart Team Panels | Hwan Wook Kim (Korea), Jae Suk Yoo (Korea) Shih-Hsien Sung (Taiwan), June Hong Kim (Korea) |
|
| 14:40-15:00 | Coffee Break | |
| 15:00-16:20 | Essentials in Management of Tricuspid Regurgitation | Takashi Matsumoto (Japan), Yong-Jin Kim (Korea) |
| TR Assessment: Limitations of Current Metrics and Emerging Solutions | Eustachio Agricola (Italy) | |
| Patient Selection for Transcatheter Therapies for TR: Who Gets What | Akhil Narang (USA) | |
| Tricuspid TEER Procedure: Techniques, Tips, and Pitfalls | Atsushi Sugiura (Japan) | |
| Tricuspid Valve Imaging for T-TEER: Optimal Imaging Guidance Using 3D TEE & ICE | Martin Swaans (Netherlands) | |
| Challenging Candidates for T-TEER and New Solutions | Fabian Barbieri (Germany) | |
| Panel Discussion | Kian Keong Poh (Singapore), Carlos Astudillo (Chile), Nhat M. Giang (Vietnam), Rafidah Abu Bakar (Malaysia), |
|
| 16:20-17:40 | 2026 SHD in Asia: New Innovations in SHD Management | Edwin Tucay (Philippine), Smonporn Boonyaratavej Songmuang (Thailand) |
| Advanced Valve Function Analysis Using 3D Echocardiography: State of the Art and What Lies Ahead? | Alex Lee (Hong Kong) | |
| Minimal Invasive & Robotic Surgery in Interventional Era | Nai-Hsin Chi (Taiwan) | |
| Transcatheter Electrosurgery and Leaflet Modification of the Valve | Simon Lam (Hong Kong) | |
| Echo-Guided Interventions in Congenital Heart Disease | Jae-Young Choi (Korea) | |
| LAA Occlusion: Present Insights and the Next Era | Takashi Matsumoto (Japan) | |
| Panel Discussion | Mungun-Ulzii Khurelbaatar (Mongolia), Le Minh Khoi (Vietnam), Mefri Yanni (Indonesia), Sung-Jin Hong (Korea) |
|
| 17:40 | Closing Remark |
| Time | Room B [Korean/English] | Faculty |
|---|---|---|
| 08:20-08:30 | Opening and Course Introduction | 박성지 (성균관의대) |
| 08:30-09:50 | The Tricuspid Valve in 360°: Measure, Guide, Judge | 박용현 (부산의대), 윤현주 (전남의대) |
| Basic of Tricuspid Regurgitation: Anatomy and Pathophysiology | 김상윤 (서울의대) | |
| Multimodality Imaging for Tricuspid Regurgitation | Akhil Narang (USA) | |
| Functional TR: When to Intervene, When to Observe? | 곽서연 (고려의대) | |
| Did It Deliver? RV Function and TR Evaluation After Intervention | 김소리 (고려의대) | |
| Panel Discussion | 김민관 (연세의대), 최홍미 (서울의대), 정수련 (성균관의대), 안효석 (가톨릭의대) | |
| 09:50-10:10 | Coffee Break | |
| 10:10-11:20 | Basic of Basic in T-TEER (English) | Eustachio Agricola (Italy), 김중선 (연세의대) |
| Preprocedural assessment and Patient Selection | Masaki Izumo (Japan) | |
| Basic of Intraprocedural TEE Imaging for T-TEER: The Must-Have Views You Cannot Miss | Eustachio Agricola (Italy) | |
| Intraprocedural ICE Imaging: Essential Views Every T-TEER Needs | Alex Lee (Hong Kong) | |
| Basic of Tricuspid TEER: Step-by-Step | Takashi Matsumoto (Japan) | |
| Panel Discussion | 정우백 (가톨릭의대), Daisuke Hachinohe (Japan), 최자연 (고려의대), Patita Sitticharoenchai (Thailand) |
|
| 11:20-12:20 | Basics of New Imaging: ICE, Mini-TEE, and Hybrid Fusion Imaging | 유철웅 (고려의대), 신준한 (아주의대) |
| 2D ICE 101: The Basics You Need to Start | 임홍의 (중앙의대) | |
| 3D ICE for Beginners: Lessons from Our Early Experience | 이용준 (연세의대) | |
| Getting Started with Mini-TEE: Advantages and Early Experience | 서희경 (연세의대) | |
| First Steps in Hybrid Fusion Imaging: When and How to Use | 조익성 (연세의대) | |
| Panel Discussion | 김창신 (연세의대), 신승용 (가톨릭의대), 김선오 (영남의대), 이오현 (연세의대) | |
| 12:20-13:30 | Luncheon Session (Sponsored Session)-한독 | 도준형 (인제의대) |
| Redefining Standard of Care for Amenable Fabry Disease with First Oral Chaperone Galafold® | 이주희 (충북의대) | |
| Patient First Considerations in Treating and Managing Fabry Disease | 진정연 (을지의대) | |
| 13:30-14:40 | The Aortic Stenosis in 360°: Measure, Guide, Judge | 홍명기 (연세의대), 김주한 (전남의대) |
| Aortic Valve Anatomy: What You Must Know | 김호진 (울산의대) | |
| Echo Cardiographic Measure, Interpret, And Decide. Are We Getting It Right? | 이사민 (울산의대) | |
| Reading TAVI CT from A to Z: What to Look For, What to Decide | 정정임 (가톨릭의대) | |
| Follow-up of Prosthetic Aortic Valve: What to Look For, What to Do | 박진오 (인제의대) | |
| Panel Discussion | 박종일 (영남의대), 김미진 (부산의대), 최익준 (가톨릭의대), 황병희 (가톨릭의대) | |
| 14:40-15:00 | Coffee Break | |
| 15:00-16:00 | Aortic Regurgitation in 360°: Measure, Guide, Judge | 정남식 (필메디스의원), 김웅 (영남의대) |
| Echo Cardiographic Measure, Interpret, Decide: When the Numbers Lie | 김인철 (계명의대) | |
| Multimodal Imaging for Aortic Regurgitation: Rvol Criteria of AR by CMR | 구현정 (울산의대) | |
| Up-to-Date Interventional Treatment of AR | Karlie Li-Tan Yang (Taiwan) | |
| Up-to-Date Surgical Treatment of AR | 손봉연 (부천세종병원) | |
| Panel Discussion | 표원경 (연세의대), 박진선 (아주의대), 정준창 (영남의대), 서영주 (연세의대) | |
| 16:00-17:20 | Plugging the Gap: Anatomy-Driven Device Selection | 정조원 (연세의대), 강웅철 (가천의대) |
| LAAO Device Selection: Matching the Device to the Appendage | 신승용 (가톨릭의대) | |
| ASD Closure - From Rim Deficiency to Device Choice | 은영민 (연세의대) | |
| Closing the PFO: Long Tunnel, Atrial Septal Aneurysm - Does the Device Change? | 이상엽 (중앙의대) | |
| Closing the PVL: Who Needs It, and How I Do It | 강도윤 (울산의대) | |
| Panel Discussion | 정세용 (연세의대), 신정훈 (연세의대), 박준빈 (서울의대), 정준창 (영남의대) |
| Time | Room C [Korean/English] | Faculty |
|---|---|---|
| 08:20-08:30 | Opening and Course Introduction | 전종근 (부산의대) |
| 08:30-09:50 | Fabry Disease Across Asian Countries: A Multinational Perspective (English) | 전종근 (부산의대), Wen-Chung Yu (Taiwan) |
| Fabry Disease in Korea: Registry and Real-World Data | 서지원 (연세의대) | |
| Fabry Disease and GLA Gene Variations: The Taiwanese Clinical Landscape | Feng-Jung Yang (National Taiwan University Hosp., Taiwan) | |
| Fabry Disease in Taiwan: Insights from National Cohort | Chih-Hung Lai (Taichung Veterans General Hosp., Taiwan) | |
| Fabry Disease in Japan: Prevalence and Screening Strategy | Jun Kido (Kumamoto Univ., Japan) | |
| Panel Discussion | 이준화 (성균관의대), 박봉수 (인제의대), Feng-Jung Yang (Taiwan), Jun Kido (Japan) |
|
| 09:50-10:10 | Coffee Break | |
| 10:10-11:20 | Fabry Disease: Clinical Research Presentation | 최지용 (대구가톨릭의대), 손영배 (아주의대) |
| Perifoveal Microvascular Alterations in Fabry Disease | 이지은 (부산의대) | |
| Beyond Resting Parameters: Multimodal Monitoring for Fabry Disease | 이선화 (연세의대) | |
| Characterizing Audiological Profiles in Fabry Disease | 이현민 (부산의대) | |
| Current Treatment Status and Clinical Outcomes of Patients with FD | 박삼엘 (순천향의대) | |
| Panel Discussion | 오지영 (연세의대), Zhe-Hao Piao (China), 김계환 (경상의대), 윤상곤 (부산의대) | |
| 11:20-12:20 | Basic Research in Fabry Disease: From Experimental Models to Novel Therapies | 김재호 (부산의대), 신성희 (인하의대) |
| siRNA Lipid Nanoparticles Ameliorate Fabry Disease Phenotype | 정병하 (가톨릭의대) | |
| Abnormal Mitochondrial ROS Levels Suggest a Ferroptosis-Prone Phenotype in Fabry Disease Patient-Derived Intestinal Organoids | 김형식 (부산치대) | |
| Therapeutic Potential of Lomerizine on Fabry Vasculopathy | 한용만 (KAIST) | |
| Panel Discussion | 배성아 (연세의대), 전종근 (부산의대), 김수진 (부산의대), 서지원 (연세의대) | |
| 12:20-13:30 | Luncheon Session (Sponsored Session)-사노피 | 정욱진 (가천의대) |
| Beyond Diagnosis: What Decades of Real-World Evidence Reveals in Fabry Disease | 김경희 (인천세종병원) | |
| From High-Risk Screening to Early Treatment: Why Dose Matters in Fabry Disease | 김인철 (계명의대) | |
| 13:30-14:40 | Genetics in Structural Heart Disease | 김신재 (울산의대), 조은주 (가톨릭의대) |
| Basics for Genetic Testing for Cardiologists | 손영배 (아주의대) | |
| Evolution of Genetic Testing: Past, Now, and Future | 장미애 (성균관의대) | |
| Interpretation of Genetic Tests for Cardiomyopathies: Case-based Learning | 설창안 (GC 녹십자) | |
| Genetic Counseling in Structural Heart Disease | 황수진 (울산의대) | |
| Panel Discussion | 이주희 (충북의대), 이수용 (부산의대), 남종호 (영남의대), 박상신 (명지병원) | |
| 14:40-15:00 | Coffee Break | |
| 15:00-16:15 | Hot Topics in Hypertrophic Cardiomyopathy | 박정랑 (경상의대), 최정현 (부산의대) |
| Multimodality Imaging in the Diagnosis & Management of HCM | 송재관 (울산의대) | |
| Cardiac Myosin Inhibitors in Obstructive HCM | 소문승 (아주의대) | |
| Mitral Valve Disease in HCM: SAM, Intrinsic MV Abnormalities | 박찬순 (울산의대) | |
| All About CMR in HCM: From Thickness to Tissue Characterization | 박은아 (서울의대) | |
| Panel Discussion | 이희정 (계명의대), 윤세정 (국민건강보험 일산병원), 황지원 (건국의대), 임하정 (차의대) | |
| 16:15-17:30 | Hot Topics in Cardiac Amyloidosis | 박태호 (동아의대), 김미정 (가톨릭의대) |
| My Practical Tips for Catching Cardiac Amyloidosis | 이상현 (부산의대) | |
| Reading the Amyloid Heart: What CMR Sees | 홍유진 (연세의대) | |
| Treating Amyloidosis: What's Here, What's Next | 김다래 (성균관의대) | |
| Genetic Screening of TTR Amyloidosis: International Perspective | Chih-Hung Lai (Taichung Veterans, Taiwan) | |
| Panel Discussion | 이누리 (전남의대), 이정원 (연세의대), 김형윤 (고려의대), 정현주 (명지병원) |
Education and Research Center for Rare and Structural heart disease (ERCRS)
1F, Baek-song Blg., Hakdong-ro 11-gil 56, Gangnam-gu, Seoul, Korea Zip: 06039
E-mail: echo360@echo360.co.kr | Office: +82-2-6002-1394 / 1392 | Fax: +82-2-583-0980
Business registration number: 507-82-76327 | Representative: Geu-Ru Hong
1F, Baek-song Blg., Hakdong-ro 11-gil 56, Gangnam-gu, Seoul, Korea Zip: 06039
E-mail: echo360@echo360.co.kr | Office: +82-2-6002-1394 / 1392 | Fax: +82-2-583-0980
Business registration number: 507-82-76327 | Representative: Geu-Ru Hong
